A Prospective Randomized Phase II Trial of CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for Microsatellite Stable Locally Advanced Rectal Cancer (TORCH-iTNT)
Latest Information Update: 04 Mar 2024
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Toripalimab (Primary)
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- Acronyms TORCH-iTNT
Most Recent Events
- 04 Mar 2024 New trial record